Impact of most promising Ebola therapies on survival: a secondary analysis during the tenth outbreak in the Democratic Republic of Congo
Prompt identification and treatment, along with enhanced supportive care (such as replenishing fluids and electrolytes and managing symptoms), significantly improve survival chances. Concurrently, administering vaccines and using mAb114, REGN-EB3, and, to some extent, Remdesivir further increase patient survival rates.
Authors
- Pierre Akilimali (ORCID: https://orcid.org/0000-0002-3828-6214)
- Nguyen Toan Tran (ORCID: https://orcid.org/0000-0001-7134-7878)
- Esther Mamu Kikwango
Institutions
- University of Technology Sydney (AU)
- University of Geneva (CH)
- University of Kinshasa (CD)
Publication Details
- Journal
- Virology Journal
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1186/s12985-025-02766-y
- Citations
- 3
- Primary Topic
- Viral Infections and Outbreaks Research
- Type
- article
- Field-Weighted Citation Impact
- 4.19